The increasing demand for specific immunological study and therapeutic design has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using multiple expression systems, including prokaryotic hosts, higher cell cultures, and baculovi